Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Axsome Therapeutics (AXSM) Net Income (2022 - 2026)

Axsome Therapeutics' Net Income history spans 5 years, with the latest figure at -$64.5 million for Q1 2026.

  • On a quarterly basis, Net Income fell 8.63% to -$64.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$188.3 million, a 32.33% increase, with the full-year FY2025 number at -$183.2 million, up 36.21% from a year prior.
  • Net Income hit -$64.5 million in Q1 2026 for Axsome Therapeutics, down from -$28.6 million in the prior quarter.
  • Over the last five years, Net Income for AXSM hit a ceiling of -$11.2 million in Q1 2023 and a floor of -$98.7 million in Q4 2023.
  • Historically, Net Income has averaged -$56.5 million across 5 years, with a median of -$61.2 million in 2022.
  • Biggest five-year swings in Net Income: skyrocketed 71.64% in 2023 and later tumbled 508.27% in 2024.
  • Tracing AXSM's Net Income over 5 years: stood at -$61.2 million in 2022, then tumbled by 61.09% to -$98.7 million in 2023, then grew by 24.06% to -$74.9 million in 2024, then soared by 61.84% to -$28.6 million in 2025, then crashed by 125.76% to -$64.5 million in 2026.
  • Business Quant data shows Net Income for AXSM at -$64.5 million in Q1 2026, -$28.6 million in Q4 2025, and -$47.2 million in Q3 2025.